Thus, we performed in vitro experiments, which showed that lnc-ITSN1-2 promoted IBD CD4+ T cell activation and proliferation, and stimulated Th1/Th17 cell differentiation through regulating IL-23R. Here, IL23R is linked to inflammatory bowel disease.